Martingale Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Martingale Asset Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	+66,324	New	+$2.23M	0.06%	357

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Martingale Asset Management's CLMT Position: Q2 2026 in Review

Martingale Asset Management opened a new position in Calumet Specialty Products (CLMT) in Q2 2026: 66,324 shares worth $2.39M. The stake represents 0.06% of the portfolio and ranks #357 among its holdings.

188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Martingale Asset Management held 66,324 shares of Calumet Specialty Products worth $2.39M as of Q2 2026.
Calumet Specialty Products was a new Martingale Asset Management position in Q2 2026.
Calumet Specialty Products made up 0.06% of Martingale Asset Management's portfolio in Q2 2026, its #357 holding.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.